GlassScriptPhysician profile
Catherine Garcia
NPI 1124317821
$25,050.98
in general payments reported to CMS, 2019-2025
41 companies · $4,449 in 2025
The $4,449 reported for 2025 was more than what 84% of Rheumatology providers received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,492 · 2020: $955 · 2021: $2,336 · 2022: $4,019 · 2023: $4,963 · 2024: $4,837 · 2025: $4,449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,849.51 |
| Education | $399.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $3,715.39 | 2019-2025 | Tavneos, Evenity, Enbrel |
| Abbvie INC. | $3,286.59 | 2019-2025 | |
| Janssen Biotech, INC. | $3,023.51 | 2019-2025 | Tremfya, Simponi Aria |
| Ucb, INC. | $2,378.43 | 2019-2025 | Cimzia, Bimzelx, Fintepla |
| Novartis Pharmaceuticals Corporation | $1,722.11 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,376.69 | 2019-2025 | Benlysta, Nucala |
| Pfizer INC. | $1,050.46 | 2019-2025 | |
| Radius Health, INC. | $1,028.70 | 2019-2025 | Tymlos |
| E.R. Squibb & Sons, L.L.C. | $1,013.86 | 2019-2025 | Orencia, Sotyktu |
| Astrazeneca Pharmaceuticals LP | $953.64 | 2022-2025 | Saphnelo |
| Lilly USA, LLC | $787.12 | 2019-2024 | Taltz |
| Horizon Therapeutics Plc | $763.63 | 2019-2023 | Krystexxa |
| Janssen Scientific Affairs, LLC | $601.39 | 2019-2022 | |
| Ani Pharmaceuticals, INC. | $533.48 | 2023-2025 | Purified Cortrophin Gel |
| Genentech USA, INC. | $456.46 | 2019-2025 | Actemra |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.